Business
The General Catalyst Institute, launched in the U.S. in September, is expanding into India and inviting policymakers and entrepreneurs in the region to collaborate.
The company will use the funds to strengthen its research and development capabilities.
The aim of the acquisitions is to accelerate the company's involvement in two major growth areas and improve patient care.
According to Bloomberg, the brain-implant chipmaker raised $93 million in funding, increasing the startup's valuation to approximately $500 million.
DarioHealth, Clover Health and eHealth also released third-quarter financial results.
HATCo will spend a total of $550 million in capital funding to invest in technologies and innovation.
The company also reported Q3 2024 earnings, noting total revenue of $76.4 million, adjusted EBITDA of $7.3 million and a net loss of $14.7 million.
The acquisition includes all of NeuroReality's assets, including its flagship rehabilitation product, Koji's Quest.
The company will use the funds to expand in Asian and U.S. markets, advance its AI algorithms and grow its workforce.
The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.